MENU
FOLD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Amicus Therapeutics (FOLD) Ownership - Who owns Amicus Therapeutics?
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
47 Hulfish Street
Phone
+1 609 662-2000
Employees
517
Web
https://www.amicusrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.46B
P/E Ratio
N/A
Total Cash
249.95M
Projected Growth
N/A
Total Debt
443.64M
Revenue
528.3M
Risk (Beta)
0.22
Dividend Yield
N/A
Total Cash/Share
0.81
Total Debt/Equity
46.37
Revenue/Share
1.74 USD as % of share price
Fundamentals
FOLD
Capitalization
2.46B
P/E Ratio
N/A
Risk (Beta)
0.22
Dividend Yield
N/A
Total Cash
250M
Total Cash/Share
0.81
Total Debt
444M
Total Debt/Equity
46.37
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.74%
Revenue
528M
ROE
N/A
Book Value
194M
P/B Ratio
12.66
Cash Flow
N/A
Earnings
-0.18
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.94M
Current Ratio
3.39
Current Revenue Per Employee
300012.03
Dividends Per Share - Security
N/A
EBITDA
29.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
90.09
Revenue To Assets
-7.18
Shares Held By Institutions
6.6B
Shares Outstanding - Current
307M
Total Liabilities
591M
Total Volume MTD
N/A
Value
-1
Gain YTD
-15.074
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of orally active drugs to treat human genetic diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
47 Hulfish Street
Phone
+1 609 662-2000
Employees
517
Web
https://www.amicusrx.com